The PA Research Foundation held their second annual Research Awards on Tuesday 27 November. A record amount of $1.85 million in crucial funding has been committed to transformational health and medical research across 12 research projects and initiatives at the PA Hospital Campus in 2019.
The research grants were awarded to clinically lead, collaborative teams in five specific research categories as directed by PARF donors. The donor directed model for distributing grants introduced in 2018 allows the funds to support the most innovative and groundbreaking research projects, leading to improved patient care in preferred areas.
PA Research Foundation CEO Damian Topp said the Foundation is committed to investing in research that is novel in concept, allowing us the opportunity to support the next big medical discovery.
"Through our Research Awards we are providing our brightest minds with crucial funding required to unearth groundbreaking medical discoveries.
"This reinforces the importance of donations and support from the wider community. We are so excited to see what lies ahead for 2019, knowing that the funds are being placed in good hands," said Damian.
The Research Awards are made possible thanks to the generous support from the Foundation's donors and partners, including ALH Group, Aveo, Spirit Hotels, Coca-Cola Amatil, St George Bank and Network Ten, and community of supporters.
Six research teams were awarded $100,000 to support the first year of their project and four research teams received continuation of funding from their 2018 project grant.
Additionally, the Foundation has also committed $300,000 in funding to the Metro South Health Breast Cancer Institute and $200,000 to Cancer Wellness Initiative.
The successful projects include:
Improving cardiovascular health outcomes in women undergoing irradiation for breast cancer
Increasing the number of breast cancer therapeutic antibody possibilities, patient choices and success rates (continuation of 2018 project grant)
Translation of the Pathobiology and Portable, MRI-based Quantification of Mammographic Density (MD) for Improved Breast Cancer Prevention and Treatment (continuation of 2018 project grant)
Multifaceted precision approach to high risk prostate cancer (continuation of 2018 project grant)
Development of a novel drug to prevent skin cancer in solid organ transplant recipients
Head and neck lymphoedema treatment: An examination and development of current standards of care
Queensland Bladder Cancer Initiative (QBCI) (continuation of 2018 research grant)
Towards improving patient-important outcomes in haemodialysis
Embracing digital disruption for more responsive care and fewer fall-injuries in hospitals.
Establishment of a microbiome bank to enable new probiotic treatment possibilities
An additional $250,000 will also be dedicated to 2nd and 3rd year funding for one of the newly awarded 2019 projects, to be determined at the half-yearly review in June 2019.
The PA Research Foundation is also proud to be supporting the following projects in 2019:
Ab BRAIN Project
Antibodies and the Brain: Recent Advances in Immunolobiology informing Neuroscience
Improving outcomes for patients with melanoma brain metastases using novel personalised and response-adapted treatment strategies.